BioLight Life Sciences Ltd (BOLT) — Net Asset Quality Index
BioLight Life Sciences Ltd (BOLT) has a Net Asset Quality Index of 94.7% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of ILA42.41 Million minus total liabilities of ILA2.24 Million yields net assets of ILA40.17 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check BioLight Life Sciences Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
BioLight Life Sciences Ltd Net Asset Quality Index Over Time (2005–2025)
This chart shows how BioLight Life Sciences Ltd's Net Asset Quality Index has evolved across 19 annual periods from 2005 to 2025. As of December 2025, the index stands at 94.7%, representing net assets of ILA40.17 Million against total assets of ILA42.41 Million ILA. See what is BioLight Life Sciences Ltd's book value for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for BioLight Life Sciences Ltd (2005–2025)
The table below presents the year-by-year Net Asset Quality Index for BioLight Life Sciences Ltd from 2005 to 2025, covering 19 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see BOLT stock market capitalisation.
| Year | Quality Index | Net Assets (ILA) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 94.7% | ILA40.17 Million | ILA42.41 Million | ILA2.24 Million | ▲ +4.6 pp |
| 2024 | 90.1% | ILA30.74 Million | ILA34.12 Million | ILA3.38 Million | ▼ -0.5 pp |
| 2023 | 90.6% | ILA30.30 Million | ILA33.45 Million | ILA3.15 Million | ▼ -3.6 pp |
| 2022 | 94.2% | ILA53.69 Million | ILA57.01 Million | ILA3.32 Million | ▼ -1.5 pp |
| 2021 | 95.7% | ILA61.42 Million | ILA64.17 Million | ILA2.75 Million | ▲ +3.0 pp |
| 2020 | 92.7% | ILA60.11 Million | ILA64.83 Million | ILA4.72 Million | ▲ +1.8 pp |
| 2019 | 90.9% | ILA68.15 Million | ILA74.95 Million | ILA6.80 Million | ▲ +4.8 pp |
| 2018 | 86.2% | ILA77.80 Million | ILA90.28 Million | ILA12.49 Million | ▲ +53.7 pp |
| 2017 | 32.4% | ILA8.03 Million | ILA24.76 Million | ILA16.73 Million | ▼ -14.0 pp |
| 2016 | 46.5% | ILA16.41 Million | ILA35.31 Million | ILA18.90 Million | ▼ -27.9 pp |
| 2015 | 74.4% | ILA47.06 Million | ILA63.27 Million | ILA16.21 Million | ▲ +10.7 pp |
| 2014 | 63.7% | ILA25.74 Million | ILA40.43 Million | ILA14.70 Million | ▼ -0.7 pp |
| 2013 | 64.4% | ILA22.11 Million | ILA34.33 Million | ILA12.22 Million | ▼ -24.7 pp |
| 2012 | 89.1% | ILA37.34 Million | ILA41.89 Million | ILA4.55 Million | ▲ +9.7 pp |
| 2011 | 79.5% | ILA23.55 Million | ILA29.63 Million | ILA6.08 Million | ▲ +52.6 pp |
| 2010 | 26.8% | ILA2.72 Million | ILA10.14 Million | ILA7.42 Million | ▼ -32.3 pp |
| 2009 | 59.2% | ILA13.31 Million | ILA22.49 Million | ILA9.18 Million | ▲ +42.5 pp |
| 2006 | 16.6% | ILA8.01 Million | ILA48.16 Million | ILA40.15 Million | ▼ -70.2 pp |
| 2005 | 86.8% | ILA17.70 Million | ILA20.39 Million | ILA2.69 Million | — |